{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:37:21Z","timestamp":1762018641310,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.pcad.2019.11.019","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T09:14:22Z","timestamp":1575278062000},"page":"479-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Endpoints for tricuspid regurgitation trans-catheter therapy trials"],"prefix":"10.1016","volume":"62","author":[{"given":"Rebecca T.","family":"Hahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ori","family":"Ben-Yehuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin B.","family":"Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2019.11.019_bb0005","doi-asserted-by":"crossref","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM and Thompson A. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease. A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. (2017).","DOI":"10.1161\/CIR.0000000000000503"},{"key":"10.1016\/j.pcad.2019.11.019_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/hrt.2006.095281","article-title":"Management of tricuspid valve regurgitation","volume":"93","author":"Antunes","year":"2007","journal-title":"Heart."},{"key":"10.1016\/j.pcad.2019.11.019_bb0015","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1161\/CIRCULATIONAHA.108.842773","article-title":"The tricuspid valve: current perspective and evolving management of tricuspid regurgitation","volume":"119","author":"Rogers","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2019.11.019_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.echo.2017.09.010","article-title":"Clinical outcome of isolated tricuspid regurgitation in patients with preserved left ventricular ejection fraction and pulmonary hypertension","volume":"31","author":"Bar","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2019.11.019_bb0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","article-title":"Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)","volume":"83","author":"Singh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0030","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ahj.2007.07.030","article-title":"Epidemiology of pure valvular regurgitation in the large middle-aged African American cohort of the Atherosclerosis Risk in Communities study","volume":"154","author":"Fox","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0035","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jtcvs.2006.08.049","article-title":"Emerging opportunities for cardiac surgeons within structural heart disease","volume":"132","author":"Stuge","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2019.11.019_bb0040","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jcmg.2014.07.018","article-title":"Clinical outcome of isolated tricuspid regurgitation","volume":"7","author":"Topilsky","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.11.019_bb0045","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1093\/eurheartj\/ehy352","article-title":"Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history","volume":"39","author":"Prihadi","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcmg.2018.11.021","article-title":"Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment","volume":"12","author":"Bartko","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.pcad.2019.11.019_bb0055","first-page":"196","article-title":"Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction","volume":"140","author":"Benfari","year":"2019"},{"key":"10.1016\/j.pcad.2019.11.019_bb0060","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.jacc.2015.04.011","article-title":"Functional tricuspid regurgitation: a need to revise our understanding","volume":"65","author":"Dreyfus","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1540-8175.2011.01565.x","article-title":"Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation","volume":"29","author":"Najib","year":"2012","journal-title":"Echocardiography."},{"key":"10.1016\/j.pcad.2019.11.019_bb0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ahj.2007.11.010","article-title":"Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations","volume":"155","author":"Kwak","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0075","first-page":"20","article-title":"Tricuspid valve replacement subsequent to previous open heart surgery","volume":"5","author":"Hornick","year":"1996","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.pcad.2019.11.019_bb0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1010-7940(00)00598-4","article-title":"Outcome following isolated tricuspid valve replacement","volume":"19","author":"Mangoni","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2019.11.019_bb0085","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.amjcard.2006.03.047","article-title":"Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mitral valve surgery and role of tricuspid annular systolic velocity","volume":"98","author":"Kwon","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jtcvs.2004.12.044","article-title":"Reoperations after tricuspid valve repair","volume":"130","author":"Bernal","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.pcad.2019.11.019_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007597","article-title":"Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation","volume":"6","author":"Alqahtani","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2019.11.019_bb0100","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.jacc.2017.10.039","article-title":"National trends and outcomes in isolated tricuspid valve surgery","volume":"70","author":"Zack","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0105","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.jacc.2016.01.063","article-title":"Transcatheter therapies for treating tricuspid regurgitation","volume":"67","author":"Rodes-Cabau","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0110","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jcin.2017.08.011","article-title":"The international multicenter TriValve registry: which patients are undergoing transcatheter tricuspid repair?","volume":"10","author":"Taramasso","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.pcad.2019.11.019_bb0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jamacardio.2019.0535","article-title":"Anatomic relationship of the complex tricuspid valve, right ventricle, and pulmonary vasculature: a review","volume":"4","author":"Hahn","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4244\/EIJV15I8A118","article-title":"Medical device regulation in Europe - what is changing and how can I become more involved?","volume":"15","author":"Byrne","year":"2019","journal-title":"EuroIntervention."},{"author":"Administration FaD","key":"10.1016\/j.pcad.2019.11.019_bb0125"},{"key":"10.1016\/j.pcad.2019.11.019_bb0130","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.115.020729","article-title":"Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)","volume":"133","author":"Okumura","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2019.11.019_bb0135","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"Yancy","year":"2017","journal-title":"J Card Fail"},{"key":"10.1016\/j.pcad.2019.11.019_bb0140","first-page":"1","article-title":"The role of noninvasive endpoints in predicting long-term outcomes in pulmonary arterial hypertension","author":"Wronski","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.pcad.2019.11.019_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCULATIONAHA.112.105890","article-title":"Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials","volume":"126","author":"Gabler","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2019.11.019_bb0150","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pcad.2019.11.019_bb0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacc.2015.05.049","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the Mitral Valve Academic Research Consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003358","article-title":"Exploring new endpoints for patients with heart failure with preserved ejection fraction","volume":"9","author":"Butler","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.pcad.2019.11.019_bb0165","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.jacc.2019.01.062","article-title":"6-Month outcomes of tricuspid valve reconstruction for patients with severe tricuspid regurgitation","volume":"73","author":"Nickenig","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.11.019_bb0170","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0002-8703(92)90986-6","article-title":"Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group","volume":"124","author":"Rector","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.pcad.2019.11.019_bb0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.pcad.2019.11.019_bb0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","article-title":"US valuation of the EQ-5D health states: development and testing of the D1 valuation model","volume":"43","author":"Shaw","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.pcad.2019.11.019_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Monitoring clinical changes in patients with heart failure: a comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0195","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/(SICI)1097-0258(19990615)18:11<1341::AID-SIM129>3.0.CO;2-7","article-title":"Combining mortality and longitudinal measures in clinical trials","volume":"18","author":"Finkelstein","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.pcad.2019.11.019_bb0200","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2019.11.019_bb0205","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcmg.2017.10.022","article-title":"Liver stiffness reflecting right-sided filling pressure can predict adverse outcomes in patients with heart failure","volume":"12","author":"Taniguchi","year":"2019","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019301604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019301604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:16:35Z","timestamp":1758500195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062019301604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0033062019301604"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.11.019","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endpoints for tricuspid regurgitation trans-catheter therapy trials","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}